GE HealthCare Launches Multi-Purpose Versana Premier Ultrasound
The new ultrasound platform reportedly offers a combination of enhanced imaging and AI-enabled tools to facilitate improved workflow efficiency.
The emerging artificial intelligence (AI)-enabled ultrasound system Versana Premier may promote improved imaging and efficiency across a variety of clinical settings.
In addition to fostering up to a 38 percent improvement in workflow efficiency, the Versana Premier ultrasound offers Whizz technology that offers real-time image optimization, according to GE HealthCare, the manufacturer of Versana Premier.
The newly launched Versana Premier ultrasound device reportedly offers automated labeling for transabdominal ultrasound views and provides 3D/4D capabilities for capturing fetal development, according to GE HealthCare, the manufacturer of Versana Premier. (Image courtesy of GE HealthCare.)
The company noted the FDA-cleared ultrasound device also provides AI-powered automated labeling for transabdominal ultrasound views as well as volume calculations. For OBGYN imaging, GE HealthCare said the Versana Premier features Whizz RenderLive and V-Live 2.0 enable clinicians to obtain 3D and 4D imaging of fetal development.
“Versana Premier is remarkably user-friendly and image quality in B-Mode is easy to optimize, making it possible to create amazing images," said Martin Altersberger, M.D., the director of the Echo Laboratory at State Hospital Steyr in Steyr, Austria. "The ultrasound system integrates advanced functions with optimized image quality and educational resources, which can be used in various settings. It can, therefore, adequately support clinicians in a wide range of assessments and diagnoses.”
Study: AI-Generated ADC Maps from MRI More Than Double Specificity in Prostate Cancer Detection
June 5th 2025Emerging research showed that AI-generated ADC mapping from MRI led to significant increases in accuracy, PPV and specificity in comparison to conventional ADC mapping while achieving a 93 percent sensitivity for PCa.
Can AI Assessment of PET Imaging Predict Treatment Outcomes for Patients with Lymphoma?
June 2nd 2025The use of adjunctive AI software with pre-treatment PET imaging demonstrated over a fourfold higher likelihood of predicting progression-free survival (PFS) in patients being treated for lymphoma, according to a new meta-analysis.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
